Dimension Inx develops biomaterials that create regenerative microenvironments to enhance cell functionality and restore organ function. Their technology addresses the limitations of traditional cell therapies by providing a three-dimensional matrix that promotes vascular integration and durable therapeutic responses.
Funding
$20.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PMFounders
Product
Problem
Traditional cell therapies often fail to achieve durable therapeutic responses due to poor cell engraftment and integration with surrounding tissues. The lack of a supportive three-dimensional microenvironment hinders vascularization and limits cell functionality, ultimately impeding organ function restoration.
Solution
Dimension Inx develops biomaterials that create regenerative microenvironments, enhancing cell functionality and promoting the restoration of organ function. Their approach combines materials science, advanced engineering, 3D-printing, and advanced digital manufacturing to optimize the three-dimensional blueprint for cells. These biomaterials facilitate rapid vascular engraftment and integration with surrounding tissue, leading to more durable therapeutic responses. Dimension Inx's technology aims to unlock the curative potential of cell therapies by providing the critical interactions cells need to behave more like native tissue and perform better for longer.
Target Audience
The primary target audience includes clinicians and researchers focused on regenerative medicine, specifically those working on cell therapies for organ function restoration, as well as patients with conditions like liver disease and type 1 diabetes.
Features
- 3D-printed regenerative bone graft (CMFlex) cleared by the FDA for facial reconstruction, demonstrating the platform's ability to commercialize products.
- Biomaterials platform designed to promote rapid vascular engraftment and integration with surrounding tissue.
- Focus on creating "tissue-like" environments that direct a series of biological responses, leading to exceptional regeneration.
- Development efforts focused on lead candidates for liver disease and type 1 diabetes.
- Novel 3D printable ink compositions.